Search results
Can At-Home Vision Tests Detect Active Neovascular AMD?
MedPage Today· 3 days agoThree at-home vision-monitoring tools failed to detect worsening neovascular age-related macular ...
...Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W Therapy for Dry Age...
Benzinga· 3 days agoLuxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New York, today announced receipt of a $4 million grant from the
Home vision tests offer limited diagnostic accuracy for neovascular AMD
Medical Xpress· 5 days agoNo home-monitoring vision test has the diagnostic accuracy of hospital eye service follow-up clinics...
Scientists find potential treatment target for leading cause of blindness
Investing.com· 3 days agoNew Delhi, May 2 (IANS) US scientists have found answers to why treatment for neovascular age-...
Stealth BioTherapeutics Announces Participation at Upcoming Ophthalmology Conferences
KTLA-TV Los Angeles· 3 days agoAt the OIS Retina Innovation...
A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss
Newswise· 2 days agoTwo treatments for retinal diseases, invented by Neena Haider, PhD, that currently are in clinical trials run by Ocugen, represent a conceptually broad, new approach that ...
Vision-Language Models for Feature Detection of Macular Diseases on Optical Coherence Tomography
Journal of the American Medical Association· 3 days agoThis cross-sectional study evaluates the performance of a vision-language model in performing ophthalmologic tasks related to interpretation of optical coherence tomography scans.
EYLEA HD shows promise in long-term clinical trials By Investing.com
Investing.com· 5 days agoHD clinical program during a series of presentations at the Association for Research in Vision and...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 2 days agoIn August 2023, the FDA approved Eylea HD (higher dose of Eylea) for the treatment of patients with...
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 - Ocular...
Benzinga· 3 days agoOcular Therapeutix, Inc. OCUL "Ocular", the "Company"))), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization ...